Co-win Healthcare Fund

Co-win Healthcare Fund

Co-win Healthcare Fund functions as the dedicated healthcare investment vertical of Cowin Capital (Tongchuangweiye), the Shenzhen-headquartered investment firm founded by serial entrepreneur Zheng Weihe and his wife Huang Li. The healthcare fund operates from a distributed network of US offices — Menlo Park, New York, Fairfax, Princeton, and Columbia — alongside a European presence in Luxembourg. Managing Partner Ma Shichun runs the sector-specialist team, reflecting a deliberate structure where each Cowin Capital vertical maintains autonomous investment committees within the parent's operational shell. The fund targets venture and growth-stage life sciences companies, blending direct equity investments with a trans-Pacific arbitrage approach that connects US-based biomedical startups to Chinese manufacturing, clinical trial, and distribution partnerships. Asset-class exposure spans biotech therapeutics, medical devices, diagnostics, and digital health services. The strategy relies on Cowin Capital's broader LP base and corporate network in China to accelerate commercialization for portfolio companies. The geographic remit concentrates on North American innovation hubs and Chinese scale-up markets, with deal teams evaluating opportunities in Boston, San Diego, and Shanghai's Zhangjiang Hi-Tech Park simultaneously. Investment pace and total deployment remain undisclosed, though the six-office US footprint suggests a materially resourced operation. The firm shares infrastructure and back-office functions with parent Cowin Capital, which manages several billion dollars across venture, private equity, and real asset strategies. Adjacent to investment operations, the founders support the Mangrove Conservation Foundation, a Shenzhen-registered environmental philanthropy focused on coastal wetland restoration in southern China — a structure typical of Chinese family-office ecosystems where philanthropic vehicles run parallel to for-profit investment arms. Structurally, Co-win Healthcare Fund occupies a rare niche: an autonomously managed, US-based sector fund within a Chinese parent firm that predates the wave of China-to-US family office migration of the late 2010s. Unlike newer single-family offices that relocated capital reactively, Cowin Capital established its US healthcare presence early, giving Ma Shichun's team long-standing relationships with academic medical centers, FDA-regulatory advisors, and US-based venture syndicates. That embedded position — combined with Cowin Capital's Shenzhen origination pipeline — creates a genuine two-market sourcing advantage that generalist cross-border funds cannot replicate easily.